62 related articles for article (PubMed ID: 2456759)
1. Effect of calcium channel modulators on isolated endothelial cells.
Whitmer KR; Williams-Lawson JS; Highsmith RF; Schwartz A
Biochem Biophys Res Commun; 1988 Jul; 154(2):591-605. PubMed ID: 2456759
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin-induced increases in cytosolic calcium and ionic currents in cultured bovine aortic endothelial cells.
Colden-Stanfield M; Schilling WP; Ritchie AK; Eskin SG; Navarro LT; Kunze DL
Circ Res; 1987 Nov; 61(5):632-40. PubMed ID: 2444358
[TBL] [Abstract][Full Text] [Related]
3. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
Maan AC; Ptasienski J; Hosey MM
J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
[TBL] [Abstract][Full Text] [Related]
4. Binding of the dihydropyridine calcium channel blocker (+)-[3H] isopropyl-4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-5-methoxycarbonyl-2, 6-dimethyl-3-pyridinecarboxylate (PN200-110) to RINm5F membranes and cells: characterization and functional significance.
Yaney GC; Stafford GA; Henstenberg JD; Sharp GW; Weiland GA
J Pharmacol Exp Ther; 1991 Aug; 258(2):652-62. PubMed ID: 1713965
[TBL] [Abstract][Full Text] [Related]
5. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
[TBL] [Abstract][Full Text] [Related]
6. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
Wei XY; Rutledge A; Triggle DJ
Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
[TBL] [Abstract][Full Text] [Related]
7. L-type Ca2+ channels are not involved in coronary endothelial Ca2+ influx mechanism responsible for endothelium-dependent relaxation.
Uchida H; Tanaka Y; Ishii K; Nakayama K
Res Commun Mol Pathol Pharmacol; 1999; 104(2):127-44. PubMed ID: 10634306
[TBL] [Abstract][Full Text] [Related]
8. Dihydropyridine binding and calcium channel function in clonal rat adrenal medullary tumor cells.
Kunze DL; Hamilton SL; Hawkes MJ; Brown AM
Mol Pharmacol; 1987 Apr; 31(4):401-9. PubMed ID: 2437436
[TBL] [Abstract][Full Text] [Related]
9. Calcium channel blockade inhibits platelet activating factor production by human umbilical vein endothelial cells.
Tolins JP; Melemed A; Sulciner D; Gustafson KS; Vercellotti GM
Lipids; 1991 Dec; 26(12):1218-22. PubMed ID: 1819708
[TBL] [Abstract][Full Text] [Related]
10. Modulation of agonist-induced calcium mobilisation in bovine aortic endothelial cells by phorbol myristate acetate and cyclic AMP but not cyclic GMP.
Buchan KW; Martin W
Br J Pharmacol; 1991 Oct; 104(2):361-6. PubMed ID: 1665733
[TBL] [Abstract][Full Text] [Related]
11. Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation.
Goll A; Ferry DR; Glossmann H
FEBS Lett; 1983 Jun; 157(1):63-9. PubMed ID: 6305718
[TBL] [Abstract][Full Text] [Related]
12. Interaction between prostaglandin E2 and l-cis-diltiazem, a specific blocker of cyclic nucleotide gated channels in bovine aortic endothelial cells.
Shalom R; Barki-Harrington L; Rimon G
Eur J Pharmacol; 2006 Aug; 543(1-3):8-13. PubMed ID: 16842773
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.
Messing RO; Carpenter CL; Greenberg DA
J Pharmacol Exp Ther; 1985 Nov; 235(2):407-11. PubMed ID: 2414431
[TBL] [Abstract][Full Text] [Related]
14. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
Zahradníková A; Minarovic I; Zahradník I
J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
[TBL] [Abstract][Full Text] [Related]
15. Potential-dependent allosteric modulation of 1,4-dihydropyridine binding by d-(cis)-diltiazem and (+/-)-verapamil in living cardiac cells.
Porzig H; Becker C
Mol Pharmacol; 1988 Aug; 34(2):172-9. PubMed ID: 2457793
[TBL] [Abstract][Full Text] [Related]
16. P2U receptor is linked to cytosolic Ca2+ transient and release of vasorelaxing factor in bovine endothelial cells in situ.
Miyagi Y; Kobayashi S; Nishimura J; Fukui M; Kanaide H
J Physiol; 1996 May; 492 ( Pt 3)(Pt 3):751-61. PubMed ID: 8734987
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective effect of diltiazem on endothelium-dependent relaxations in canine femoral arteries.
Rubanyi GM; Hoeffner U; Schwartz A; Vanhoutte PM
J Pharmacol Exp Ther; 1988 Jul; 246(1):60-4. PubMed ID: 2455796
[TBL] [Abstract][Full Text] [Related]
18. Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla.
Murphy BJ; Rogers CA; Sunahara RK; Lemaire S; Tuana BS
Mol Pharmacol; 1990 Feb; 37(2):173-81. PubMed ID: 2154669
[TBL] [Abstract][Full Text] [Related]
19. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine.
Glossmann H; Ferry DR; Goll A; Rombusch M
J Cardiovasc Pharmacol; 1984; 6 Suppl 4():S608-21. PubMed ID: 6083403
[TBL] [Abstract][Full Text] [Related]
20. Potassium depolarization elevates cytosolic free calcium concentration in rat anterior pituitary cells through 1,4-dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels.
Meier K; Knepel W; Schöfl C
Endocrinology; 1988 Jun; 122(6):2764-70. PubMed ID: 2453348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
